Scientists probe osteosarcoma tissue for clues on MTAP deletion
NCT ID NCT07593573
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at stored tissue samples from 100 people with advanced osteosarcoma to check for loss of the MTAP protein. Researchers want to see how common this loss is and whether it relates to cancer spread or immune system activity. No new treatment is given; the goal is to gather information that could guide future drug development.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNOHISTOCHEMISTRY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University People's Hospital
Beijing, Beijing Municipality, 100044, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can two drugs together fight Hard-to-Treat bone and Soft-Tissue cancers?
- Experimental vaccine fights sarcoma with Patient's own immune cells
- New drug hope for rare sarcomas after chemo fails
- Dietary change explored as cancer support strategy
- New drug combo aims to stall bone sarcoma in phase 2 trial
- New hope for kids with resistant cancers: targeted drug enters trial